Evaluation of MAF-1217 in Patients With DED
NCT03833882
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Evaporative Dry Eye Disease
Interventions
DEVICE:
MAF1217
OTHER:
Cationorm
Sponsor
VISUfarma SpA